Multimodality imaging reveals a gradual increase in matrix metalloproteinase activity at aneurysmal lesions in live fibulin-4 mice

Circulation: Cardiovascular Imaging

Volumn 3, Issue 5, 2010, Pages 567-577

  Kaijzel, Eric L ^a   Van Heijningen, Paula M ^b   Wielopolski, Piotr A ^b   Vermeij, Marcel ^b   Koning, Gerben A ^b   Van Cappellen, Wiggert A ^b   Que, Ivo ^a   Chan, Alan ^c   Dijkstra, Jouke ^a   Ramnath, Natasja W M ^b   Hawinkels, Lukas J A C ^a   Bernsen, Monique R ^b   Löwik, Clemens W G M ^a   Essers, Jeroen ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c PERCUROS B V   (Netherlands)

Author keywords

Aneurysm; Blood supply; Diagnostic imaging

Indexed keywords

ELASTIN; FIBULIN 4; GELATIN; GELATINASE B; GLYCOPROTEIN; MATRIX METALLOPROTEINASE; PROTEINASE; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; FIBULIN-4; MMP9 PROTEIN, MOUSE; SCLEROPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; AORTA ANEURYSM; AORTA ARCH; ARTICLE; ASCENDING AORTA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DNA MODIFICATION; ENZYME ACTIVATION; ENZYME ACTIVITY; FLUORESCENCE; IN VIVO STUDY; MOLECULAR IMAGING; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSOR; UPREGULATION; ZYMOGRAPHY; ANIMAL; AORTOGRAPHY; C57BL MOUSE; DISEASE COURSE; DISEASE MODEL; EARLY DIAGNOSIS; ENZYMOLOGY; GENETIC PROCEDURES; GENETICS; MAGNETIC RESONANCE ANGIOGRAPHY; METABOLISM; METHODOLOGY; MOUSE MUTANT; NEAR INFRARED SPECTROSCOPY; PATHOLOGY; PREDICTION AND FORECASTING; RADIOGRAPHY; SIGNAL TRANSDUCTION; THORACIC AORTA; THORACIC AORTA ANEURYSM;

ANIMALS; AORTA, THORACIC; AORTIC ANEURYSM, THORACIC; AORTOGRAPHY; BIOLOGICAL MARKERS; BIOSENSING TECHNIQUES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EARLY DIAGNOSIS; ELASTIN; ENZYME ACTIVATION; EXTRACELLULAR MATRIX PROTEINS; FLUORESCENCE; MAGNETIC RESONANCE ANGIOGRAPHY; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR IMAGING; PREDICTIVE VALUE OF TESTS; SIGNAL TRANSDUCTION; SPECTROSCOPY, NEAR-INFRARED; TOMOGRAPHY, X-RAY COMPUTED; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 77957363988     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.109.933093     Document Type: Article

References (39)

1. McLaughlin PJ, Chen Q, Horiguchi M, Starcher BC, Stanton JB, Broekelmann TJ, Marmorstein AD, McKay B, Mecham R, Nakamura T, Marmorstein LY. Targeted disruption of fibulin-4 abolishes elastogenesis and causes perinatal lethality in mice. Mol Cell Biol. 2006;26:1700-1709.
2. Hanada K, Vermeij M, Garinis GA, de Waard MC, Kunen MG, Myers L, Maas A, Duncker DJ, Meijers C, Dietz HC, Kanaar R, Essers J. Perturbations of vascular homeostasis and aortic valve abnormalities in fibulin-4 deficient mice. Circ Res. 2007;100:738-746. (Pubitemid 46594889)
3. Cudilo E, Al Naemi H, Marmorstein L, Baldwin AL. Knockout mice: Is it just genetics? Effect of enriched housing on fibulin-4(+/-) mice. PLoS One. 2007;2:e229.
4. Horiguchi M, Inoue T, Ohbayashi T, Hirai M, Noda K, Marmorstein LY, Yabe D, Takagi K, Akama TO, Kita T, Kimura T, Nakamura T. Fibulin-4 conducts proper elastogenesis via interaction with cross-linking enzyme lysyl oxidase. Proc Natl Acad Sci U S A. 2009;106:19029-19034.
5. Coucke PJ, Willaert A, Wessels MW, Callewaert B, Zoppi N, De Backer J, Fox JE, Mancini GM, Kambouris M, Gardella R, Facchetti F, Willems PJ, Forsyth R, Dietz HC, Barlati S, Colombi M, Loeys B, De Paepe A. Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome. Nat Genet. 2006;38: 452-457.
6. Judge DP, Dietz HC. Marfan's syndrome. Lancet. 2005;366:1965-1976. (Pubitemid 41713988)
7. Lemaitre V, Soloway PD, D'Armiento J. Increased medial degradation with pseudo-aneurysm formation in apolipoprotein E-knockout mice deficient in tissue inhibitor of metalloproteinases-1. Circulation. 2003; 107:333-338. (Pubitemid 36135233)
8. Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest. 2002;110:625-632. (Pubitemid 34988786)
9. Segura AM, Luna RE, Horiba K, Stetler-Stevenson WG, McAllister HA Jr, Willerson JT, Ferrans VJ. Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan's syndrome. Circulation. 1998;98: II331-II337; discussion II337-II338.
10. Ntziachristos V, Tung CH, Bremer C, Weissleder R. Fluorescence molecular tomography resolves protease activity in vivo. Nat Med. 2002; 8:757-760. (Pubitemid 34778731)
11. Weissleder R, Ntziachristos V. Shedding light onto live molecular targets. Nat Med. 2003;9:123-128. (Pubitemid 36098273)
12. Bremer C, Tung CH, Weissleder R. In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat Med. 2001;7:743-748. (Pubitemid 32588033)
13. Bremer C, Tung CH, Weissleder R. Molecular imaging of MMP expression and therapeutic MMP inhibition. Acad Radiol. 2002;9(suppl 2): S314-S315. (Pubitemid 34857705)
14. Sanz J, Fayad ZA. Imaging of atherosclerotic cardiovascular disease. Nature. 2008;451:953-957. (Pubitemid 351305938)
15. Koning GA, Krijger GC. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery. Anticancer Agents Med Chem. 2007;7:425-440. (Pubitemid 47099049)
16. Hartnell GG. Imaging of aortic aneurysms and dissection: CT and MRI. J Thorac Imaging. 2001;16:35-46. (Pubitemid 32056779)
17. Schafers M, Riemann B, Kopka K, Breyholz HJ, Wagner S, Schafers KP, Law MP, Schober O, Levkau B. Scintigraphic imaging of matrix metalloproteinase activity in the arterial wall in vivo. Circulation. 2004;109: 2554-2559. (Pubitemid 38720556)
18. Hawinkels LJ, Verspaget HW, van der Reijden JJ, van der Zon JM, Verheijen JH, Hommes DW, Lamers CB, Sier CF. Active TGF-beta1 correlates with myofibroblasts and malignancy in the colorectal adenomacarcinoma sequence. Cancer Sci. 2009;100:663-670.
19. Hawinkels LJ, Zuidwijk K, Verspaget HW, de Jonge-Muller ES, van Duijn W, Ferreira V, Fontijn RD, David G, Hommes DW, Lamers CB, Sier CF. VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis. Eur J Cancer. 2008;44: 1904-1913.
20. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
21. Mulder WJ, Douma K, Koning GA, van Zandvoort MA, Lutgens E, Daemen MJ, Nicolay K, Strijkers GJ. Liposome-enhanced MRI of neointimal lesions in the ApoE-KO mouse. Magn Reson Med. 2006;55: 1170-1174.
22. Nahrendorf M, Waterman P, Thurber G, Groves K, Rajopadhye M, Panizzi P, Marinelli B, Aikawa E, Pittet MJ, Swirski FK, Weissleder R. Hybrid in vivo FMT-CT imaging of protease activity in atherosclerosis with customized nanosensors. Arterioscler Thromb Vasc Biol. 2009;29: 1444-1451.
23. Zhang Z, van den Bos EJ, Wielopolski PA, de Jong-Popijus M, Bernsen MR, Duncker DJ, Krestin GP. In vitro imaging of single living human umbilical vein endothelial cells with a clinical 3.0-T MRI scanner. Magma. 2005;18:175-185. (Pubitemid 41428269)
24. Hellenthal FA, Buurman WA, Wodzig WK, Schurink GW. Biomarkers of abdominal aortic aneurysm progression. Part 2: Inflammation. Nat Rev Cardiol. 2009;6:543-552.
25. Hellenthal FA, Buurman WA, Wodzig WK, Schurink GW. Biomarkers of AAA progression. Part 1: Extracellular matrix degeneration. Nat Rev Cardiol. 2009;6:464-474.
26. Zhang X, Shen YH, LeMaire SA. Thoracic aortic dissection: Are matrix metalloproteinases involved? Vascular. 2009;17:147-157.
27. Deguchi JO, Aikawa M, Tung CH, Aikawa E, Kim DE, Ntziachristos V, Weissleder R, Libby P. Inflammation in atherosclerosis: Visualizing matrix metalloproteinase action in macrophages in vivo. Circulation. 2006;114:55-62. (Pubitemid 44305275)
28. Daugherty A, Cassis LA. Mouse models of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol. 2004;24:429-434. (Pubitemid 38326134)
29. Neptune ER, Frischmeyer PA, Arking DE, Myers L, Bunton TE, Gayraud B, Ramirez F, Sakai LY, Dietz HC. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet. 2003;33: 407-411. (Pubitemid 36278859)
30. Zacchigna L, Vecchione C, Notte A, Cordenonsi M, Dupont S, Maretto S, Cifelli G, Ferrari A, Maffei A, Fabbro C, Braghetta P, Marino G, Selvetella G, Aretini A, Colonnese C, Bettarini U, Russo G, Soligo S, Adorno M, Bonaldo P, Volpin D, Piccolo S, Lembo G, Bressan GM. Emilin1 links TGF-beta maturation to blood pressure homeostasis. Cell. 2006;124:929-942. (Pubitemid 43344234)
31. ten Dijke P, Arthur HM. Extracellular control of TGFbeta signalling in vascular development and disease. Nat Rev Mol Cell Biol. 2007;8: 857-869. (Pubitemid 47622560)
32. Hynes RO. The extracellular matrix: Not just pretty fibrils. Science. 2009;326:1216-1219.
33. Wang M, Zhao D, Spinetti G, Zhang J, Jiang LQ, Pintus G, Monticone R, Lakatta EG. Matrix metalloproteinase 2 activation of transforming growth factor-beta1 (TGF-beta1) and TGF-beta1-type II receptor signaling within the aged arterial wall. Arterioscler Thromb Vasc Biol. 2006;26: 1503-1509. (Pubitemid 44288975)
34. Yu Q, Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev. 2000;14:163-176. (Pubitemid 30070982)
35. Kim ES, Kim MS, Moon A. TGF-beta-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells. Int J Oncol. 2004;25:1375-1382.
36. Seomun Y, Kim J, Lee EH, Joo CK. Overexpression of matrix metalloproteinase-2 mediates phenotypic transformation of lens epithelial cells. Biochem J. 2001;358:41-48. (Pubitemid 32778096)
37. Pemberton J, Sahn DJ. Imaging of the aorta. Int J Cardiol. 2004;97(suppl 1):53-60. (Pubitemid 39601751)
38. Hyde D, de Kleine R, MacLaurin SA, Miller E, Brooks DH, Krucker T, Ntziachristos V. Hybrid FMT-CT imaging of amyloid-beta plaques in a murine Alzheimer's disease model. Neuroimage. 2009;44:1304-1311.
39. Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, Myers L, Klein EC, Liu G, Calvi C, Podowski M, Neptune ER, Halushka MK, Bedja D, Gabrielson K, Rifkin DB, Carta L, Ramirez F, Huso DL, Dietz HC. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science. 2006;312:117-121.